Q1 2015

Source filing unavailable

Q1 2015 · —

Revenue

$168.80M

−16.6% vs Q1 2014

Net Income

$16.00M

−71.2% vs Q1 2014

EPS Diluted

$0.21

−69.1% vs Q1 2014

Operating Income$25,900,000−68.8%

Operating Cash Flow$7,000,000−92.3%

Free Cash Flowderived

Same quarter

Metric	Q1 2015	Q1 2014	Q1 2013	Q1 2012
Revenue	$168.80M	$202.47M	$133.44M	$110.45M
Net Income	$16.00M	$55.47M	$30.14M	$25.10M
EPS Diluted	$0.21	$0.68	$0.36	$0.29

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR